The quality of your virtual EA relationship is determined largely in the first 30 days. Pharmaceutical and biotech CEOs who invest in a structured onboarding process get exponentially more value from their EA than those who hand off tasks piecemeal and expect the EA to figure out the rest.
This guide provides a step-by-step onboarding framework designed specifically for pharmaceutical and biotech CEOs. It covers what to do before the EA starts, during the first week, and through the first 30 days.
Before Day One: Preparation and Documentation
Execute Confidentiality Agreements First
Before transferring any access or providing any organizational context, ensure that appropriate confidentiality agreements are in place. In pharmaceutical and biotech, this means a comprehensive NDA that covers clinical data, regulatory strategy, IP information, investor relationships, and M&A discussions.
If you are using a virtual EA service, their standard NDA may need to be supplemented with a pharmaceutical-specific addendum. Review this with your legal counsel before onboarding begins.
Document Your Current Workflow
Before briefing your EA, document what your day and week actually look like. Map out:
- Recurring meetings and their purpose (leadership team, clinical review, board committees, investor calls)
- Key external relationships and their context (board members, top investors, regulatory advisors, key partners)
- Ongoing projects and their status
- Your calendar preferences: when you prefer meetings, what time blocks you want protected, and what you are willing to schedule flexibly
- Your communication preferences: response time expectations, tone guidelines, and which contacts are highest priority
This documentation does not need to be elaborate. A structured briefing document covering these areas gives your EA the context to operate independently from the first week rather than requiring constant direction.
Prepare Access and Technology
Before your EA starts, prepare the access they need:
- Calendar access (read and write permissions)
- Email access at the appropriate permission level
- Document management system access
- Project tracking tool access
- Travel booking platform access
- Any CRM or investor relations tool access
- Communication platforms (Slack workspace, Teams, etc.)
For pharmaceutical executives, make sure that any systems containing regulated or confidential information are accessed through secure, approved channels. If your company has an IT security policy for third-party access, apply it to your EA’s access configuration.
The First Week: Context and Orientation
Brief the EA on the Organization
The first substantive briefing should cover the organization’s current state: pipeline programs and their development stage, current regulatory status (upcoming filings, recent interactions, active programs), organizational structure (key direct reports and their functional domains), current strategic priorities (upcoming fundraise, partnering discussions, commercial planning), and the investor and board landscape.
This context is the foundation on which every good EA decision is built. An EA who understands the organization operates at a different level than one who is executing tasks without understanding why they matter.
Introduce the EA to Key Stakeholders
In the first week, facilitate introductions between your EA and the people they will interact with regularly: your executive assistant team (if any), your chief of staff (if applicable), your board chair or lead director, your head of investor relations, and any external service providers (legal, banking, PR) who frequently communicate with your office.
These introductions establish the EA’s authority to communicate on your behalf and reduce friction when they need to coordinate with external parties.
Run a Calendar Audit Together
Review your current calendar with your EA during the first week. Walk through upcoming commitments, explain the context of each, identify which meetings require preparation and what kind, and flag any scheduling issues that need to be addressed. This collaborative calendar review accelerates the EA’s ability to manage your schedule with appropriate judgment.
The First 30 Days: Building the Operating Model
Establish Daily and Weekly Check-In Routines
A brief daily check-in (10 to 15 minutes) in the first month helps align on priorities, address any issues, and accelerate the EA’s calibration to your working style. Many pharmaceutical CEOs prefer a morning briefing covering the day’s key meetings and any items requiring CEO input, followed by a brief end-of-day status update.
As the EA develops familiarity with your priorities and style, check-in frequency typically decreases to a few times per week.
Delegate Progressively, Not Gradually
A common mistake is delegating to the EA gradually: start with a few tasks, see how they do, and expand from there. This approach takes months to reach full value. A better approach is to delegate all clearly defined functions immediately and address specific issues as they arise.
Front-load the full scope of EA responsibilities from week one. Provide context, answer questions, and give feedback on specific outputs. The EA will make some judgment errors initially; that is expected and manageable. What is not manageable is an EA who is still learning basic scope three months into the engagement.
Provide Direct, Specific Feedback
In pharmaceutical and biotech, communication quality and judgment are critical. If an email draft does not meet your standard, explain specifically what needs to change. If a scheduling decision was wrong, explain the priority framework that should have guided a different outcome. Direct feedback in the first 30 days calibrates the EA’s judgment and improves quality rapidly.
Define Escalation Protocols
By the end of the first 30 days, your EA should have a clear framework for deciding what requires CEO input versus what they handle independently. Document this explicitly: regulatory correspondence always escalates; routine investor meeting logistics do not. Board-related communications escalate; routine scheduling with management team members does not.
This protocol reduces the number of interruptions you receive from your EA while ensuring you stay appropriately informed on items that require your judgment.
According to Harvard Business Review, the highest-performing executives delegate with clear success criteria rather than delegating tasks and then managing execution. The same principle applies to EA onboarding: define what success looks like for each function and hold the EA accountable to that standard.
Common Onboarding Mistakes to Avoid
Skipping the context-setting phase: An EA who starts executing tasks without organizational context will make avoidable judgment errors. Front-load the briefing.
Withholding access: EAs who lack the access they need to do their jobs create a shadow system where the CEO handles things the EA should be managing. Set up access completely on day one.
Managing at the task level: If you are reviewing and approving every scheduling decision or email draft, you are not using your EA effectively. Calibrate and correct, but do not supervise at the task level.
Failing to introduce the EA externally: External stakeholders who do not know your EA exists will route communications to you directly. One introduction email from you to key contacts changes this dynamic immediately.
For more guidance on selecting the right EA before you start onboarding, best virtual EA for pharma reviews the leading service options. For those evaluating dedicated EA arrangements, dedicated EA for pharma explains the dedicated service model and its onboarding advantages.
Conclusion
Onboarding a virtual executive assistant as a pharmaceutical or biotech CEO requires a structured investment of time and attention at the outset. The CEOs who make this investment consistently report that their EA delivers full value within 30 to 60 days. Those who skip the onboarding process typically underutilize their EA and conclude, incorrectly, that the model is not working.
The onboarding investment pays for itself many times over. Do it well, and you will have a trusted operational partner who makes your most demanding leadership role significantly more manageable.
Related Reading
For further context, explore How to Onboard a Virtual Executive Assistant as a Automotive CEO and How to Onboard a Virtual Executive Assistant as a Construction & Architecture CEO.